IRIS

Schadendorf, D., Wolchok, J., Neyns, B., Lebbe, C., Harmankaya, K., Verschraegen, C., et al. (2009). Activity of ipilimumab at 10mg/kg in patients with advanced melanoma is independent of baseline prognostic factors. EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, 7(2), 579-579 [10.1016/S1359-6349(09)71952-4].

Activity of ipilimumab at 10mg/kg in patients with advanced melanoma is independent of baseline prognostic factors

Maio M
2009-01-01
2009
Schadendorf, D., Wolchok, J., Neyns, B., Lebbe, C., Harmankaya, K., Verschraegen, C., et al. (2009). Activity of ipilimumab at 10mg/kg in patients with advanced melanoma is independent of baseline prognostic factors. EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, 7(2), 579-579 [10.1016/S1359-6349(09)71952-4].
1.5 Abstract in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1081144